These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 22355326
21. Heart rate variability in generalized anxiety disorder, major depressive disorder and panic disorder: A network meta-analysis and systematic review. Wang Z, Luo Y, Zhang Y, Chen L, Zou Y, Xiao J, Min W, Yuan C, Ye Y, Li M, Tu M, Hu J, Zou Z. J Affect Disord; 2023 Jun 01; 330():259-266. PubMed ID: 36914118 [Abstract] [Full Text] [Related]
22. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey--Mental Health (CCHS-MH). Deschênes SS, Burns RJ, Schmitz N. J Psychosom Res; 2015 Feb 01; 78(2):137-42. PubMed ID: 25510185 [Abstract] [Full Text] [Related]
24. Predictors of remission from generalized anxiety disorder and major depressive disorder. Kelly KM, Mezuk B. J Affect Disord; 2017 Jan 15; 208():467-474. PubMed ID: 27863710 [Abstract] [Full Text] [Related]
27. Heart and soul: heart rate variability and major depression. Kidwell M, Ellenbroek BA. Behav Pharmacol; 2018 Apr 15; 29(2 and 3-Spec Issue):152-164. PubMed ID: 29543649 [Abstract] [Full Text] [Related]
28. Increased rates of eating disorders and their symptoms in women with major depressive disorder and anxiety disorders. Garcia SC, Mikhail ME, Keel PK, Burt SA, Neale MC, Boker S, Klump KL. Int J Eat Disord; 2020 Nov 15; 53(11):1844-1854. PubMed ID: 32844425 [Abstract] [Full Text] [Related]
29. Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses. Maes M, Bonifacio KL, Morelli NR, Vargas HO, Moreira EG, St Stoyanov D, Barbosa DS, Carvalho AF, Nunes SOV. Neurotox Res; 2018 Oct 15; 34(3):489-510. PubMed ID: 29736827 [Abstract] [Full Text] [Related]
30. The differences of event-related potential components in patients with comorbid depression and anxiety, depression, or anxiety alone. Zhou X, Lin Z, Yang W, Xiang M, Zhou B, Zou Z. J Affect Disord; 2023 Nov 01; 340():516-522. PubMed ID: 37572703 [Abstract] [Full Text] [Related]
31. Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample. Ohaeri JU, Awadalla AW. Med Sci Monit; 2012 Mar 01; 18(3):CR160-73. PubMed ID: 22367127 [Abstract] [Full Text] [Related]
36. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Glassman AH, Bigger JT, Gaffney M, Van Zyl LT. Arch Gen Psychiatry; 2007 Sep 01; 64(9):1025-31. PubMed ID: 17768267 [Abstract] [Full Text] [Related]
37. Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Bruce DG, Davis WA, Dragovic M, Davis TM, Starkstein SE. Depress Anxiety; 2016 Oct 01; 33(10):960-966. PubMed ID: 27164424 [Abstract] [Full Text] [Related]
38. The influence of comorbid anxiety on the effectiveness of Cognitive Therapy and Interpersonal Psychotherapy for Major Depressive Disorder. van Bronswijk SC, Lemmens LHJM, Huibers MJH, Arntz A, Peeters FPML. J Affect Disord; 2018 May 01; 232():52-60. PubMed ID: 29477584 [Abstract] [Full Text] [Related]